Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

---

Summary

• President's Associate Presidential Professor
• Director, PGY2 Pediatric Pharmacy Residency
• Director, Pediatric Pharmacotherapy Degree Option

---

Publications & Presentations

31. Harkin M, Miller J L, Lim S Y, Neely S, Walsh C, Johnson P N. "Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit". The Annals of pharmacotherapy. 2021

32. Miller J L, Stephens K, Johnson P N, Medina M. Teaching residents how to deliver active learning during didactic lectures. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2021; 78 : 944-948

33. Lim S Y, Miller J L, Henry E, Heltsley R, Woo S, Johnson P N. Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children. Pharmacotherapy. 2021; 41 : 359-369

34. Harkin M, Johnson P N, Neely S, White L, Miller J L. Frequency and Severity of Chlorothiazide-Induced Hyponatremia in the Neonatal Intensive Care Unit. American journal of perinatology. 2021

35. Weller B M, Shaddix B P, Oschman A, Johnson P N, Neely S, Chaaban H, Williams P K, Miller J L. A Pilot Evaluation of the Possible Association of Metronidazole With Neurodevelopmental Outcomes in Premature Neonates. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2021; 26 : 455-459

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.


2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.


3. University of Oklahoma College of Medicine--Department of Pediatrics. Mentor award (for Caitlyn Bradford, PharmD). Date: 2022.


4. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2019.


5. Pediatric Pharmacy Advocacy Group. Christensen Young Investigator Award (Served as resident mentor). Date: 2016.

Education

1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.


2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.


3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.


4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.

Administrative Assignments

no results